Her, E. J. http://orcid.org/0000-0002-3446-5469
Haworth, A.
Reynolds, H. M.
Sun, Y.
Kennedy, A.
Panettieri, V.
Bangert, M.
Williams, S.
Ebert, M. A.
Funding for this research was provided by:
Australian National Health and Medical Research Council (APP1126955, APP1126955, APP1126955, APP1126955)
University of Melbourne (Melbourne International Research Scholarship)
Prostate Cancer Foundation of Australia (Movember Young Investigator Grant, Movember Young Investigator Grant)
Cancer Therapeutics (Top up Funding)
Department of Education, Australian Government (Research Training Program Scholarship)
Article History
Received: 19 November 2019
Accepted: 13 May 2020
First Online: 13 July 2020
Ethics approval and consent to participate
: For this study, a subset of five patients was selected from a cohort of PCa patients who participated in a Human Research Ethics Committee approved project (Reference number: HREC/15/PMCC/125) at the Peter MacCallum Cancer Centre, Melbourne, Australia. Informed written consent was obtained from all patients.
: Not applicable.
: The authors declare that they have no competing interests.